A detailed history of Bartlett & Co. LLC transactions in Novartis Ag stock. As of the latest transaction made, Bartlett & Co. LLC holds 151,046 shares of NVS stock, worth $14.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
151,046
Previous 153,046 1.31%
Holding current value
$14.9 Million
Previous $15.6 Million 3.14%
% of portfolio
0.25%
Previous 0.28%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$92.27 - $101.54 $184,540 - $203,080
-2,000 Reduced 1.31%
151,046 $15.1 Million
Q3 2023

Oct 10, 2023

SELL
$94.73 - $105.13 $257,855 - $286,163
-2,722 Reduced 1.75%
153,046 $15.6 Million
Q2 2023

Jul 14, 2023

SELL
$92.52 - $104.91 $1.09 Million - $1.24 Million
-11,825 Reduced 7.06%
155,768 $15.7 Million
Q1 2023

Apr 06, 2023

SELL
$80.03 - $92.81 $822,548 - $953,901
-10,278 Reduced 5.78%
167,593 $15.4 Million
Q4 2022

Jan 04, 2023

SELL
$75.55 - $92.52 $256,416 - $314,012
-3,394 Reduced 1.87%
177,871 $16.1 Million
Q3 2022

Oct 17, 2022

SELL
$74.61 - $87.26 $212,489 - $248,516
-2,848 Reduced 1.55%
181,265 $13.8 Million
Q2 2022

Aug 02, 2022

SELL
$80.52 - $93.75 $2.52 Million - $2.94 Million
-31,329 Reduced 14.54%
184,113 $15.6 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $43,499 - $49,206
-543 Reduced 0.25%
215,442 $18.9 Million
Q4 2021

Mar 08, 2022

SELL
$79.7 - $88.13 $393,558 - $435,185
-4,938 Reduced 2.24%
215,985 $18.9 Million
Q3 2021

Oct 15, 2021

SELL
$81.78 - $95.14 $90,775 - $105,605
-1,110 Reduced 0.5%
220,923 $18.1 Million
Q2 2021

Jul 19, 2021

SELL
$85.24 - $94.15 $668,025 - $737,853
-7,837 Reduced 3.41%
222,033 $20.3 Million
Q1 2021

Apr 19, 2021

SELL
$83.5 - $98.47 $570,472 - $672,747
-6,832 Reduced 2.89%
229,870 $19.6 Million
Q4 2020

Jan 20, 2021

SELL
$78.07 - $94.43 $318,837 - $385,652
-4,084 Reduced 1.7%
236,702 $22.4 Million
Q3 2020

Oct 20, 2020

BUY
$82.14 - $91.0 $510,500 - $565,565
6,215 Added 2.65%
240,786 $20.9 Million
Q2 2020

Aug 03, 2020

SELL
$80.93 - $91.1 $250,235 - $281,681
-3,092 Reduced 1.3%
234,571 $20.5 Million
Q1 2020

May 07, 2020

SELL
$70.67 - $99.01 $692,353 - $970,000
-9,797 Reduced 3.96%
237,663 $19.6 Million
Q3 2019

Nov 04, 2019

SELL
$85.54 - $94.26 $845,562 - $931,760
-9,885 Reduced 3.84%
247,460 $21.5 Million
Q2 2019

Jul 24, 2019

SELL
$75.4 - $92.8 $14.4 Million - $17.7 Million
-190,834 Reduced 42.58%
257,345 $23.5 Million
Q1 2019

Apr 23, 2019

SELL
$75.32 - $86.15 $236,580 - $270,597
-3,141 Reduced 0.7%
448,179 $0
Q4 2018

Jan 23, 2019

SELL
$73.66 - $82.02 $261,198 - $290,842
-3,546 Reduced 0.78%
451,320 $38.7 Million
Q3 2018

Oct 15, 2018

SELL
$66.94 - $77.43 $87,624 - $101,355
-1,309 Reduced 0.29%
454,866 $39.2 Million
Q2 2018

Jul 31, 2018

SELL
$64.91 - $73.36 $725,758 - $820,238
-11,181 Reduced 2.39%
456,175 $34.5 Million
Q1 2018

Apr 25, 2018

SELL
$70.39 - $84.15 $166,894 - $199,519
-2,371 Reduced 0.5%
467,356 $37.8 Million
Q4 2017

Jan 19, 2018

SELL
$72.33 - $77.64 $242,594 - $260,404
-3,354 Reduced 0.71%
469,727 $39.4 Million
Q3 2017

Oct 23, 2017

BUY
$74.14 - $77.27 $35.1 Million - $36.6 Million
473,081
473,081 $40.6 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bartlett & Co. LLC Portfolio

Follow Bartlett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.